Dr Farshad Guirakhoo | CSO
GeoVax, Inc.

Dr Farshad Guirakhoo, CSO, GeoVax, Inc.

Before joining GeoVax in 2015, Dr. Guirakhoo served in senior management and scientific roles within the biotechnology industry with Vaxess Technologies, Hookipa Biotech, Sanofi Pasteur, Acambis, Inc. and OraVax, Inc. In his scientific career, Dr. Guirakhoo has filed over 90 patent applications and is author/co-author of more than 80 peer reviewed publications, including book chapters. He was instrumental in the development and commercialization of the Imojev Japanese encephalitis virus vaccine and the Dengvaxia vaccine for Dengue virus


Day Two 11th October, Human @ 16:15

Use of MAV-VLP platform for development of vaccines for infectious diseases and cancer


Day Three 12th October, Human @ 09:25

Technology Showcase 2 : Development of a novel vaccine for Zika that does not bear the inherent risk of inducing ADE

back to speakers